← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2013Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 1, 2012
Prothena Biosciences Inc— Founded
Drugs by trial phase (6 distinct, 15 trials)
Indications
Recent trials (18)
- NCT07174310CollaboratorPhase 3Dec 31, 2025
- NCT06699680Lead sponsorPhase 1Nov 8, 2024
- NCT04973137Lead sponsorPhase 3Aug 30, 2021
- NCT04777331CollaboratorPhase 2May 5, 2021
- NCT03336580Lead sponsorPhase 1Apr 5, 2018
- NCT03154047Lead sponsorPhase 2Jun 30, 2017
- NCT03100149CollaboratorPhase 2Jun 27, 2017
- NCT02632786Lead sponsorPhase 2Mar 1, 2016
- NCT02630901Lead sponsorPhase 1Mar 1, 2016
- NCT02613182Lead sponsorPhase 2Feb 1, 2016
- NCT02458677Lead sponsorPhase 1May 1, 2015
- NCT02312206Lead sponsorPhase 3Feb 1, 2015
- NCT02157714Study directorPhase 1Jun 1, 2014
- NCT02157714Lead sponsorPhase 1Jun 1, 2014
- NCT02095171Lead sponsorPhase 1Mar 1, 2014
Details
- Founded
- South San Francisco, CA, US Jun 1, 2012
- Last known activity
- Dec 31, 2025